P/E ratio for Enzo Biochem (ENZ)

P/E ratio history for Enzo Biochem from 2001 to 2023

PE ratio at the end of each year

P/E ratio for similar companies or competitors

Company	P/E ratio	P/E ratio differencediff.	Country
RadNet RDNT	-292	24,609.57%	🇺🇸 USA
Quest Diagnostics DGX	23.0	-2,047.75%	🇺🇸 USA
LabCorp LH	30.2	-2,658.78%	🇺🇸 USA
Psychemedics PMD	-6.83	478.46%	🇺🇸 USA
Qiagen QGEN	31.4	-2,760.18%	🇳🇱 Netherlands
NeoGenomics NEO	-17.6	1,387.50%	🇺🇸 USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.